BCRX

#1599
BioCryst Pharmaceuticals, Inc. - Common Stock
8.9 1 USD
-1.87%
부문: 헬스케어
베이스: USD
수익 통화: USD
일일 변동 비율
8.91
8.91
년간 변동
6.00
11.31
일일 변동
-1.87%
월간 변동
-1.11%
6달 변화
+25.85%
년간 변동율
-17.88%
이전 종가
9.0 8
Open
8.9 1
저가
8.9 1
High
8.9 1
양
277
전체 차트 열기 Full chart

Financials

개요 성명 통계
4분기 연간
손익계산서 대차대조표 현금 흐름
값 202020212022202320242025 TTM

BioCryst Pharmaceuticals, Inc. - Common Stock

BioCryst Pharmaceuticals, Inc. is an American pharmaceutical company headquartered in Durham, North Carolina. The company is a late stage biotech company that focuses on oral drugs for rare and serious diseases. BioCryst's antiviral drug peramivir was approved by FDA in December 2014. It has also been approved in Japan, Korea, and China.

뉴스